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Office testsAbstract Objectives: Vestibular migraine (VM) is one of the most common causes of episodic ver-
tigo. Several studies have reported abnormal cervical vestibular evoked myogenic potentials
(cVEMPs) in VM patients. Recent studies have investigated the diagnostic values of ocular vestibu-
lar myogenic evoked potentials (oVEMPs) in VM patients. However, they were few and rarely
attempted to correlate the finding with the results of other vestibular tests. So this study aimed
to investigate both cVEMPs and oVEMPs in VM patients and to correlate their results with other
clinical findings.
Subjects and methods: The study group consisted of twenty adult patients with criteria of definite
VM. The control group included age and gender matched twenty healthy subjects. For all subjects
detailed history and basic audiologic evaluation were done. Vestibular evaluation included clinical
office tests and VEMPs (cVEMPs and oVEMPs). Patients were examined during interictal period
and in the absence of vertigo.
Results: True vertigo was experienced in 60% of patients, while 40% patients had sense of
unsteadiness. Office tests for vestibulo-spinal reflex were abnormal in 5 patients (25%). Abnormal
oVEMPs responses were more frequent (No. = 19 ‘‘95%”) than cVEMPs (No = 15 ‘‘75%”). The
main abnormality was prolonged latency and/or decreased amplitude. Affection was more bilateral
while absent response was less frequently encountered. Significant correlation was found between
abnormal office tests and VEMPs abnormalities.
Conclusions: Both cVEMPs and oVEMPs abnormalities were detected in VM patients. Abnor-
mal office tests were among patients with severe VEMPs affection during interictal period.
 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Vestibular migraine (VM) is one of the most common causes
of episodic vertigo and is increasingly recognized among neu-.
12 L.H. Khalil et al.rologist and migraine specialist.1 The association between
episodic vertigo and migraine was noted long ago. However,
attempts at a more scientific analysis of this relationship have
only begun over the last 20 years.2
Patients with migraine frequently have vestibular com-
plaints ranging from frank vertigo to less specific symptoms
of dizziness, unsteadiness and head motion intolerance. Some
patients may be free from migraine attacks for years when
VM first manifests itself.3
VM usually yields pathological nystagmus in most of the
patients during the episode.4 However, between the attacks
there is no specific testing abnormality. Vestibular tests can
yield abnormal results such as vestibulo-ocular tests. Examina-
tion of static posturograms of migraine patients even without
vertigo demonstrated deterioration in equilibrium parameters
favoring central vestibular involvement.5 Vestibulo-spinal
pathway abnormality was also reported in VM patients as
detected by cVEMPs testing.6 Recently the characteristics and
the diagnostic values of oVEMPs testing have been investigated
in VM patients. However, VEMPs studies rarely attempted to
correlate with other clinical tests.
Accordingly, this work was designed to evaluate both
cVEMPs and oVEMPs in MV patients and try to correlate
their results with clinical vestibular office tests’ findings.
2. Subjects and methods
2.1. Subjects
2.1.1. Study group
Study group included twenty patients complaining of
vestibular migraine (VM) (18 females ‘90%’, 2 males ‘10%’).
Their age ranged from 18 to 62 years (mean 36.9 ± 12.9).
Duration of migraine ranged from 8 months to 8 years (mean
6 ± 2.6 years).
They were selected according to the criteria of the Neuhau-
ser and Lempert’ criteria7 for definite MV:
A. Episodic vestibular symptoms of at least moderate
severity (interfere with the daily activity).
B. Current or previous history of migraine according to
International Headache Classification ICHD-3-beta8
(intermittent disabling headache lasts 4–72 hours and
associated with nausea, vomiting, photophobia and/or
phonophobia).
C. One of the migrainous symptoms during two or more
attacks of vertigo.
D. Other causes are excluded.
All patients were examined in the absence of migrainous
attacks and their last vertiginous attack was at least 3 weeks
prior to enrollment in the study.
2.1.2. Control group
The control group included twenty healthy subjects (15
females ‘75%’, 5 males ‘25%’) with no history of intense head-
ache or vertigo. Their mean age was 38.7 (±12.7) years (range
18–60 years).
Inclusion criteria for all subjects.- No history of ear disease, head trauma, cerebro-vascular
insult or intake of ototoxic drugs.
- No history of neurological disorders apart from migraine.
- No use of medication for migraine prophylaxis.
- Normal middle ear functions evidenced by otological exam-
ination, tympanometry and acoustic reflex thresholds.
The procedures followed were ethically approved by the
ENT Department Board. All subjects participated in this study
were informed and they gave their consent prior to study.
2.2. Methods
Detailed history with particular emphasis on migrainous and
vertiginous attacks was obtained from the study group. Pure-
tone and speech audiometry was performed for all subjects
using Interacoustics audiometer model AC 40. Middle ear
functions were assessed using Madsen tympanometry model
Zodiac 901.
Vestibular evaluation included clinical vestibular office test-
ing and vestibular evoked myogenic potentials (cVEMPs and
oVEMPs).
2.2.1. Clinical vestibular office test battery
1. Oculomotor tests (Range of eye movement, gaze, Smooth
pursuit and Saccadic Tests).
2. Vestibulo-ocular reflex tests (search for spontaneous nys-
tagmus, Head shake test and Head thrust Test (HTT).
3. Positional and positioning (Dix-Hallpike) tests.
4. Vestibulo-spinal reflex tests (Modified clinical test of sen-
sory integration and balance (CTSIB), Fukuda stepping
test and Tandem walk).
2.2.2. Vestibular evoked myogenic potentials (VEMPs)
Air conduction cVEMPs and oVEMPs were examined using
Evoked potential measuring System Biologic Navigator Pro V.
2.2.2.1. cVEMPs. Monaural acoustic stimulation with ipsilat-
eral recording was employed for recording cVEMPs. The sub-
ject was in a sitting position. Surface potentials predominantly
electromyograph (EMG) were recorded with three Ag/AgCl
electrodes. The active electrode was placed on the symmetrical
sites at midpoints of each sternocleidomastoid (SCM) muscles,
with a reference electrode on the suprasternal notch and a
ground electrode on the forehead. The electrode impedance
was kept under 5 kX. EMG signals were amplified, band
pass-filtered between 10 and 1000 Hz and monitored to main-
tain background muscle activity. Acoustic stimuli were deliv-
ered at 90 dBnHL using head phone. Stimuli consisted of
500 Hz Blackman-gated tone bursts with a 2 ms rise/fall time
and no (0 ms) plateau presented at a rate of 5.1p/s with rar-
efaction polarity. The analysis time was 100 ms and 200
responses were averaged for each run, while the subject was sit-
ting with the head rotating sideways toward one shoulder to
activate the sternocleidomastoid muscle. The initial positive–
negative biphasic waveform comprised peaks P13–N23. At
least two consecutive averages were recorded from each side
Table 1 Distribution of abnormal VEMPs in the study group.
Unilateral No. (%) Bilateral No. (%)
cVEMPs
Absent response 2(10%) –
Delayed latencies 7(35%) 6(30%)
Decreased amplitude 1(5%) –
oVEMPs
Absent response 4(20%) –
Delayed latencies 2(10%) 12(60%)
Decreased amplitude 5(25%) –
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amplitude P13–N23, and interaural amplitude difference
(IAD) ratio were measured. The latter was defined as the dif-
ference in the amplitudes of the right and left ears divided by
the sum of amplitudes.
2.2.2.2. oVEMPs.Monaural stimulation with contralateral eye
recording was employed for recording oVEMPs. The subject
was in a sitting position. The active electrode was placed on
the face just inferior and at the center of the lower eye lid.
The reference electrode was positioned at the chin and one
ground electrode was on the forehead.9 The electrode impe-
dance was kept under 5 kῼ. During recording, the subject
was instructed to look upward at a small fixed target more
than 2 m from the eyes. The vertical eye position was at an
angle of approximately 30–35 above horizontal.
The EMG signals were amplified and band pass filtered
between 10 and 1000 Hz. Acoustic stimuli were the same as
cVEMP test. The analysis time for each response of 50 ms
and 100 responses were averaged for each run. The initial neg-
ative–positive biphasic waveform comprised peaks NI and PI.
Two runs were performed to confirm the reproducibility.
Conversely, oVEMPs were termed absent when the biphasic
waveform was lacking. The latencies of peaks nI and pI,
amplitude nI–pI, and interaural amplitude difference (IAD)
ratio were measured.
2.3. Statistical analysis
All data were collected and analyzed using an IBM computer
statistical package for social science (SPSS) program version
13 by expert statistician. Mean and Standard Deviation (SD)
were calculated. Paired t test was used for two dependent
means, Student ‘‘t” test was used for two independent means
with normal distribution while a comparison between two
independent groups for non-parametric data was performed
using Wilcoxon Rank Sum test. Ranked Spearman correlation
test was used for non-parametric data. P< 0.05 was consid-
ered significant.
3. Results
There was no statistical difference as regards age and gender
distribution between control and study groups (P> 0.05).
3.1. Demographic data of symptoms
Among 20 VM patients, 17 patients (85%) had normal pure-
tone hearing thresholds at different frequencies (250–
8000 Hz) and excellent speech discrimination scores. Only
three subjects were found to have mild high frequency hearing
loss. All subjects had normal middle ear functions.
VM patients reported aural symptoms during migrainous
attack. The most frequent was phonophobia (60%) followed
by tinnitus (35%), ear fullness (25%), and earache (15%).
None of the subjects reported hearing impairment.
Duration of vestibular symptoms ranged from 4 months to
8 years (mean 3.5 ± 2.3 years). The onset of dizziness ranged
from months to years after the onset of migraine headache
in patients. Twelve patients (60%) had true vertigo while 8
patients (40%) had unsteadiness sense (transient imbalance).Vestibular episodes ranged from seconds up to 48 h. Episodes
lasting for hours were more frequent in 11 patients (55%), with
a mean duration of 4 h (range 4–8 h).
The majority of patients had vestibular symptoms occur-
ring before the onset or during the headache in 60% of
patients. Patients who had a longer duration of migraine had
a longer duration and more frequency of vestibular episodes.
3.2. Vestibular office tests
Oculomotor tests, vestibulo-ocular reflex tests, positional and
positioning tests were normal in all patients. However,
vestibulo-spinal reflex tests were abnormal in 5 patients (25%).
The Fukuda test was abnormal in 5 patients (25%), Mod-
ified CTSIB was abnormal in 4 of them (when eyes were closed
and the patient was standing on a compliant surface). Tandem
gait was also abnormal in 4 patients who showed abnormality
either in Fukuda or CTSIB test.
3.3. VEMP test results
3.3.1. VEMP results in the control group
cVEMPs and oVEMPs were successfully recorded in all sub-
jects in the control group when either the right or left ear
was stimulated. No statistical difference was detected between
the right and left side recordings so the mean (X) and standard
deviation (SD) of 40 ears were calculated (Table 2). Abnormal
response was considered beyond 2(SD) of the control group
parameters.
3.3.2. VEMP results in the study group
Among 20 VM patients, 5 patients (25%) had normal
cVEMPs response. Abnormal cVEMPs was found in 15 sub-
jects (75%). While the majority of VM patients (no = 19
‘95%’) had abnormal oVEMPs response. Abnormal response
was either absent, delayed or of diminished amplitude. Abnor-
mal response was unilateral or bilateral. Distribution of abnor-
mal VEMPs is represented in (Table 1). VM case with
abnormal VEMPs traces is represented in Fig. 1.
VM patients had a statistically significant prolonged mean
of P13 and N23 latencies compared to control groups.
Although the mean of P13–N23 amplitude was lower in VM
patients it was statistically insignificant compared to normal
subjects (Table 2).
Similarly there was highly statistically significant prolonged
mean of N1 and P1 latencies compared to the control group.
Figure 1 VM patient with abnormal cVEMPs (delayed P13 and N23 latencies) and abnormal oVEMP (delayed N1 and P1) latencies in
both ears. Diminished oVEMPs (N1–P1) amplitude in the left ear with 33% inter-aural amplitude difference.
Table 2 Comparison between control and study groups regarding different cVEMPs and oVEMPs parameters.
Control group X (SD) Study group
Right X (SD) P Left X (SD) P
cVEMPs
P13 latency (ms) 16.65(0.8) 18.1(0.45) <0.001 17.5(0.55) <0.001
N23 Latency (ms) 24.3(0.6) 26.1(0.5) <0.001 25.1(0.4) <0.001
Amplitude (lv) 62.7(20.6) 57.5(23.01) >0.05 54.9(20.72) >0.05
oVEMPs
n1 latency (ms) 11.1(0.5) 13.3(1.1) <0.001 13.4(1.1) <0.001
p1 latency (ms) 15.9(0.45) 17.3(1.1) <0.001 17.4(1.1) <0.001
Amplitude(lv) 14.6(4.8) 11.2(6.9) >0.05 13.88(7.53) >0.05
14 L.H. Khalil et al.Although the mean of n1–p1 amplitude was lower in VM
patients it was statistically insignificant (Table 2).
3.4. Correlation studies
The prolonged latencies in both oVEMPs and cVEMPs were
significantly correlated in almost all parameters (Table 3).
There was no significant correlation (P> 0.05) between
age of patients, duration of migraine, duration of vestibular
disease, duration of vertiginous spells and both cVEMPs and
oVEMPs response parameters (latencies and amplitudes).
However, there was a significant correlation between
abnormal Fukuda, modified CTSIB, tandem gait tests andTable 3 Correlation study between oVEMP and cVEMP
parameters in VM patients.
P13 N23
r p r p
n1 0.42 <0.05 0.25 0.13
p1 0.40 <0.05 0.39 <0.05both cVEMPs and oVEMPs abnormalities (P< 0.05). For
further analysis a detailed distribution of VEMPs abnormalities
in the 5 patients with abnormal CTSIB and gait is represented
in Table 4.
4. Discussion
In the present study only 3 subjects were found to have mild
high frequency hearing loss. However, many patients had aural
symptoms. The most frequent was phonophobia (60%) fol-
lowed by tinnitus (35%), ear fullness (25%), and earache
(15%). An observation which deserves more attention is that
aural symptoms were bilateral in the majority of subjects
and occurred more frequently during the dizziness attacks.
Tinnitus and ear fullness persisted in some patients even in
the headache free periods.
Similar aural symptoms have been documented by Dash
et al.10 who reported that phonophobia was the most common
auditory symptom (70%) followed by tinnitus (50%). Hazzaa
and El Mowafy11 on a large number of VM patients (98 sub-
jects) also found the most prevalent aural symptom was
phonophobia (50%) followed by tinnitus (29.5%) and aural
fullness (21.4%). Hearing loss was also rare (3.1%). Aural
symptoms were also bilateral in 83% of their subjects.
Table 4 Distribution of abnormalities in oVEMPs and cVEMPs in VM patients with abnormal office tests.
No. Fukuda Gait CTSIB oVEMPs cVEMPs
1 +ve +ve +ve Bilateral delayed latency
Bilateral reduced amplitude
Bilateral delayed latency
Left reduced amplitude
2 +ve +ve +ve Right absent response Left delayed latency & reduced amplitude Right absent response
Left delayed latency
3 +ve +ve +ve Right delayed latency and reduced amplitude
Left absent response
Bilateral delayed latency
Normal amplitude
4 +ve +ve +ve Bilateral delayed latency & reduced amplitude Bilateral delayed latency
Unilateral reduced amp
5 +ve +ve ve Bilateral delayed latency
Right reduced amplitude
Normal
+ve: abnormal, ve: normal.
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were quite varied. They included episodic true vertigo (60%),
other forms of imbalance were reported by 40% of subjects.
These findings are in agreement with Neuhauser et al.12 who
also reported that all forms of dizziness can occur with
migraine. Johnson13 found that true episodic vertigo alone
was described by 44% of patients, Neuhauser et al.12 found
that the most common duration of the vertigo in vestibular
migraine patients was between 5 and 60 min. Hazzaa and El
Mowafy11 also reported pure vertigo in 30% of patients and
vertigo associated with imbalance in 35% of their subjects.
The duration of the dizziness ranged between minutes (57%)
up to hours (40%), rarely persisted for days (3%).
Neuhauser et al.12 found temporal association between
dizziness and headache in 66% of patients. Other investigators
found such association in only 34% of their patients.11
In the current study patients with a longer duration of
migraine had a longer duration and frequency of vestibular
episodes. This agrees with Neuhauser et al.14 who found that
the longer the duration of migraine the higher the prevalence
of the vestibular symptoms. They suggested that with a long
duration, there would be recurrent transient migraine induced
ischemia that may cause damage of peripheral vestibular struc-
tures. Also, we found the onset of dizziness ranged from
months to years after the onset of migraine headache in
patients. This agrees with Dash et al.10 who suggested that
vestibulopathy may appear later in the course of migraine.
4.1. Clinical vestibular office tests
Vestibulo-ocular reflex test assesses the visual compensations
that brain makes for head rotation. In the current study all
tests for VOR as well as ocular motor tests did not show any
abnormality, a finding which appeared contradictory to other
researches.
Brevern et al.4 found pathological spontaneous or
positional nystagmus in 70% of the patients during acute
vestibular migraine attacks. They inferred that spontaneous
nystagmus indicates a central (i.e. cortical) origin of the nys-
tagmus whereas positional would indicate a peripheral (i.e.
vestibular system) origin. Of these people in the study 70%
had a positive Romberg sign.
Spontaneous and positional nystagmus with near normal
caloric values was also reported by many authors.4,15,16,11
A proposed explanation for such contradiction is due to thedifference in clinical presentation of VM patients at the time
of testing. In the current study patients evaluated them in
between attacks when they were free from both headache
and dizziness. Other researchers were conducting tests in the
acute phase of headache or dizziness.
While office tests did not show VOR abnormality in the
current study, VSR abnormality was detected in five subjects
(25%) by Modified CTSIB when eyes were closed. Four out
of those five patients could not perform Tandem gait and
had a significant deviation during the Fukuda stepping test.
VSR abnormality has been reported by Baker et al.17. Their
migrainous patients had lower scores during functional gait
assessment compared to the control group. Among migrainous
patients, VM subgroup had the lowest scores. Also, in agree-
ment with our results, Shalaby et al.18 reported abnormal pos-
turographic findings in 37.5% of migrainous patients during
headache free periods, mostly in conditions 5 and 6 denoting
vestibulo-spinal dysfunction in migraineurs.
4.2. VEMPs in study group
In the present study a large percentage of patients showed
VEMPs abnormalities. Latency prolongation was the most fre-
quent abnormality in both cVEMPs and oVEMPs and was sta-
tistically significant. Complete absence of the response was less
encountered. Although a general trend of amplitude reduction
of VEMP was observed in VM patients, the difference did not
reach a statistically significant level.
These results are in agreement with many investigators.
Moallemi et al.19 reported delayed p13 latency values and
low amplitudes of the cVEMPs in migraine patients. Baier
et al.6 found that the cVEMPs amplitudes were significantly
and bilaterally reduced compared to those of controls. Gozke
et al.20 investigated oVEMPs in migraine patients. The mean
latencies of N1 and P1 were significantly longer and N1–P1
amplitudes were lower than those in the control group. A com-
plete absence of the response was also less encountered in
18.6% of patients. Zuniga et al.21 found that VM patients
had reduced cVEMPs and oVEMPs amplitudes relative to
controls.
A number of theories related to the vascular and neural
mechanisms in the pathophysiology of the migraine have been
proposed in the studies to date. The question of concern was
whether VEMPs abnormalities can be localized into central
or peripheral involvement of the vestibular system.
16 L.H. Khalil et al.cVEMPs and oVEMPS are myogenic potentials that are
generated by two different pathways; VSR and VOR respec-
tively. They depend on the functional integrity of the otolith
end organs, vestibular nerve, vestibular nuclei and neuromus-
cular plates. It is conceivable that damage to any of these
structures results in the affection of potentials’ parameters.
In the current study the prevalent VEMPs abnormalities
were bilaterally prolonged latencies, so this is in favor of cen-
tral site of lesion. Probably the vestibular nuclei in the brain-
stem where two pathways converge. This agrees with the
speculations of previous researchers who had similar prolonga-
tion of VEMPs, particularly when bilateral.
This assumption is also supported by Shin et al.22 who doc-
umented central vestibular dysfunction in vestibular migraine
patients when used F-fluorodeoxy glucose (FDG) positron-
emission tomography (PET) during (ictal) and between (inter-
ictal) attacks of vestibular migraine.
In contrast, reduced amplitude and absent response may be
suggestive ofperipheral than central vestibular dysfunction.Baier
et al.6 provided evidence that structures in the inner ear, such as
the saccule and utricle may be affected in around two-thirds of
patients with vestibular migraine andMenie`re’s disease. Further-
more, more than half of the patients (52%) with vestibular
migraine showed bilateral reduced amplitudes. These parallels
between the two disorders implicate a possible underlying link
in the pathogenesis of Menie`re’s disease and vestibular migraine.
So from the current findings of VEMPs abnormalities, cen-
tral vestibular dysfunction is highly suggestive, however,
peripheral dysfunction could not be excluded in some patients.
4.3. Correlation studies between clinical office tests and VEMPs
There was no statistically significant correlation between age,
the duration of migraine and the duration of vestibular disease
and VEMPs abnormalities.
Abnormal VSR office tests were significantly correlated with
abnormal cVEMPs and oVEMPs. On further analysis, it was
found that those patients had also severe compromise of
VEMPs response (bilateral, in both oVEMPs and cVEMPs).
In fact those patients were chronic migraine patients having
the disease for more than 5–10 years. This may reflect that office
VSR test abnormalitiesmight be detected clinically among those
with more severe affection during interictal periods.
5. Conclusions
Even in between attacks, some VM patients might have signif-
icant functional limitations in their daily activities whenever
other sensory inputs for balance are not available. Clinical
office vestibular tests could be useful in the detection of these
functional limitations. This important heath implication
emphasizes the need for further studies on the role of vestibu-
lar rehabilitation in vestibular migraine patients.
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